PMID- 37934870
OWN - NLM
STAT- MEDLINE
DCOM- 20240214
LR  - 20240429
IS  - 1477-0377 (Electronic)
IS  - 1358-863X (Linking)
VI  - 29
IP  - 1
DP  - 2024 Feb
TI  - Real-world effect of iloprost in patients with chronic limb-threatening ischemia 
      (CLTI): A cohort study.
PG  - 67-69
LID - 10.1177/1358863X231209263 [doi]
FAU - Dari, Loubna
AU  - Dari L
AUID- ORCID: 0000-0001-6759-4980
AD  - Department of Vascular Medicine, Bordeaux University Hospital, Bordeaux, France.
AD  - Inserm U1219 Bordeaux Population Health Team AHeaD: Assessing Health in a 
      Digitalizing Real-World Setting Pharmacoepi and beyond, University of Bordeaux, 
      Bordeaux, France.
FAU - Constans, Joel
AU  - Constans J
AD  - Department of Vascular Medicine, Bordeaux University Hospital, Bordeaux, France.
FAU - Boulon, Carine
AU  - Boulon C
AD  - Department of Vascular Medicine, Bordeaux University Hospital, Bordeaux, France.
FAU - Caradu, Caroline
AU  - Caradu C
AD  - Department of Vascular Surgery, Bordeaux University Hospital, Bordeaux, France.
FAU - Lapebie, Francois-Xavier
AU  - Lapebie FX
AD  - Department of Vascular Medicine, Toulouse University Hospital, Toulouse, France.
FAU - Bura-Riviere, Alessandra
AU  - Bura-Riviere A
AD  - Department of Vascular Medicine, Toulouse University Hospital, Toulouse, France.
FAU - Chastaingt, Lucie
AU  - Chastaingt L
AD  - Department of Vascular Medicine, Limoges University Hospital, Limoges, France.
FAU - Lacroix, Philippe
AU  - Lacroix P
AD  - Department of Vascular Medicine, Limoges University Hospital, Limoges, France.
FAU - Bezin, Julien
AU  - Bezin J
AD  - Inserm U1219 Bordeaux Population Health Team AHeaD: Assessing Health in a 
      Digitalizing Real-World Setting Pharmacoepi and beyond, University of Bordeaux, 
      Bordeaux, France.
FAU - Pariente, Antoine
AU  - Pariente A
AD  - Inserm U1219 Bordeaux Population Health Team AHeaD: Assessing Health in a 
      Digitalizing Real-World Setting Pharmacoepi and beyond, University of Bordeaux, 
      Bordeaux, France.
LA  - eng
PT  - Letter
DEP - 20231107
PL  - England
TA  - Vasc Med
JT  - Vascular medicine (London, England)
JID - 9610930
RN  - JED5K35YGL (Iloprost)
SB  - IM
MH  - Humans
MH  - Chronic Limb-Threatening Ischemia
MH  - Iloprost/adverse effects
MH  - Cohort Studies
MH  - *Peripheral Arterial Disease/diagnosis/drug therapy/etiology
MH  - Ischemia/diagnosis/drug therapy/etiology
MH  - Limb Salvage
MH  - Treatment Outcome
MH  - Retrospective Studies
MH  - Chronic Disease
MH  - *Endovascular Procedures/adverse effects
OTO - NOTNLM
OT  - amputation
OT  - chronic limb-threatening ischemia (CLTI)
OT  - comparative effectiveness
OT  - prostanoids
COIS- Declaration of conflicting interestsDr Lapebie and Dr Bura-Riviere reports the 
      receipt of personal fees from Bayer HealthCare SAS outside the submitted work. 
      The other authors have nothing to disclose.
EDAT- 2023/11/07 18:42
MHDA- 2024/02/10 14:47
CRDT- 2023/11/07 14:53
PHST- 2024/02/10 14:47 [medline]
PHST- 2023/11/07 18:42 [pubmed]
PHST- 2023/11/07 14:53 [entrez]
AID - 10.1177/1358863X231209263 [doi]
PST - ppublish
SO  - Vasc Med. 2024 Feb;29(1):67-69. doi: 10.1177/1358863X231209263. Epub 2023 Nov 7.